Trial Number
894-18
Condition
Brain Tumor
Participant Age Range
3 years to 22 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“ACNS1422: A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients”
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma.